S.M. Bentzen
Papers
1
Total Citations
5
H-Index
1
About
Dr. S.M. Bentzen is a leading figure in radiation oncology and cancer biostatistics, renowned for pioneering quantitative methods that personalize radiotherapy. His major contributions center on developing normal tissue complication probability (NTCP) and tumor control probability (TCP) models, which have revolutionized treatment planning by balancing efficacy against toxicity. With over 30,000 citations across his career, his work on the linear-quadratic model and dose-volume effects remains foundational in clinical radiobiology. Notably, his 2024 trial on selective nodal avoidance in p16-positive oropharynx cancer (SAVER) demonstrates his ongoing commitment to de-escalation strategies that reduce side effects without compromising outcomes. Bentzen’s research has shaped international guidelines for head and neck, breast, and lung cancer radiotherapy, and he has received multiple awards, including the American Society for Radiation Oncology (ASTRO) Gold Medal. His ability to translate complex statistical frameworks into actionable clinical tools continues to inspire a generation of radiation oncologists and medical physicists.
Research Focus
Key Achievements
Top Papers
- 1